Robin Feldman

Q: What Schools Are Affiliated With Robin Feldman

Robin Feldman is affiliated with the following schools: University of California College of the Law, San Francisco, Stanford University

Robin Feldman's AcademicInfluence.com Rankings

Robin Feldman

Law

#1556

World Rank

#1949

Historical Rank

#770

USA Rank

International Law

#1583

World Rank

#1882

Historical Rank

#718

USA Rank

law Degrees

Robin Feldman

Economics

#4185

World Rank

#4735

Historical Rank

#1137

USA Rank

economics Degrees

Download Badge

Law
Economics

Robin Feldman's Degrees

PhD Economics Stanford University

Why Is Robin Feldman Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Robin Feldman is a law professor, researcher, and author best known for her contributions to intellectual property and health care law. Feldman is the Arthur J. Goldberg Distinguished Professor of Law at the University of California, Hastings College of Law Feldman is a widely cited expert on intellectual property and health care law, particularly as it relates to the pharmaceutical industry, drug policy, and drug pricing.

(See a Problem?)

Robin Feldman's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

The Open Source Biotechnology Movement: Is it Patent Misuse? (2004) (35)
Do Patent Licensing Demands Mean Innovation? (2015) (30)
May your drug price be evergreen (2018) (29)
The Role of Science in Law (2009) (29)
Patent Licensing, Technology Transfer, & Innovation (2016) (27)
The Giants Among Us (2011) (24)
The America Invents Act 500: Effects of Patent Monetization Entities on US Litigation (2012) (23)
May your drug price be evergreen. (2018) (23)
Artificial Intelligence in the Health care Space: How We Can Trust What We Cannot Know (2019) (19)
The Insufficiency of Antitrust Analysis for Patent Misuse (2004) (18)
Understanding and Incentivizing Biosimilars (2012) (17)
The AIA 500 Expanded: The Effects of Patent Monetization Entities (2013) (16)
Defensive Leveraging in Antitrust (1999) (15)
Rethinking Patent Law (2012) (15)
Whose body is it anyway? Human cells and the strange effects of property and intellectual property law. (2010) (12)
Patent Demands and Initial Public Offerings (2015) (12)
Open Source, Open Access, and Open Transfer: Market Approaches to Research Bottlenecks (2008) (12)
Drug Wars: A New Generation of Generic Pharmaceutical Delay (2016) (12)
Regulatory Property: The New IP (2016) (11)
Considerations on the Emerging Implementation of Biometric Technology (2004) (10)
Drug Wars: How Big Pharma Raises Prices and Keeps Generics off the Market (2017) (9)
Coming of Age for the Federal Circuit (2014) (9)
Patent Trolling — Why Bio & Pharmaceuticals Are at Risk (2014) (8)
Patent and Antitrust: Differing Shades of Meaning (2008) (8)
Database from Empirical Evidence of Drug Pricing Games - A Citizen's Pathway Gone Astray (2016) (8)
Copyright at the Bedside: Should We Stop the Spread? (2013) (8)
Law's Misguided Love Affair with Science (2008) (7)
Plain Language Patents (2008) (7)
Intellectual Property Wrongs (2012) (7)
Negative innovation: when patents are bad for patients (2021) (7)
Patent Demands & Startup Companies: The View from the Venture Capital Community (2013) (7)
Historic Perspectives on Law & Science (2008) (6)
Drugs, Money, and Secret Handshakes (2019) (6)
The CRISPR Revolution: What Editing Human DNA Reveals About the Patent System's DNA (2016) (6)
Pharmaceutical Industry Funding to Patient-Advocacy Organizations: A Cross-National Comparison of Disclosure Codes and Regulation (2019) (5)
The Fatal Attraction of Pay-for-Delay (2019) (5)
Imagining new legalities : privacy and its possibilities in the 21st century (2012) (5)
Open Letter on Ethical Norms in Intellectual Property Scholarship (2016) (5)
Pharma: Greed, lies, and the poisoning of America, GeraldPosnerAvid University Press, New York, NY, 2020. 539 pp. $21.49 (cloth) (2021) (3)
A Patient Price Guide for Prescription Medication (2022) (3)
Combination therapy patents: a new front in evergreening (2021) (3)
The Role of the Subconscious in Intellectual Property Law (2009) (3)
A Citizen's Pathway Gone Astray - Delaying Competition from Generic Drugs. (2017) (3)
Is patent enforcement efficient? (2018) (3)
Perverse Incentives: Why Everyone Prefers High Drug Prices -- Except for Those Who Pay the Bills (2018) (3)
Penn Law: Legal Scholarship Repository Penn Law: Legal Scholarship Repository An Accurate Diagnosis, But Is There a Cure? An Accurate Diagnosis, But Is There a Cure? (2011) (3)
Federalism, First Amendment & Patents: The Fraud Fallacy (2015) (2)
The Gender Gap in Startup Catalyst Organizations: Bridging the Divide between Narrative and Reality (2016) (2)
The Sound and Fury of Patent Activity (2018) (2)
Technology Law: Artificial Intelligence: Trust and Distrust (2019) (2)
The Pace of Change: Non-practicing Entities and the Shifting Legal Landscape (2015) (2)
Ending Patent Exceptionalism & Structuring the Rule of Reason: The Supreme Court Opens the Door for Both (2014) (2)
Competition at the Dawn of Artificial Intelligence (2018) (2)
A Conversation on Judicial Decision-Making (2012) (2)
Rethinking Rights in Biospace (2005) (2)
Consumption Taxes and the Theory of General and Individual Taxation (2001) (2)
Learning from Past Mistakes — The US Patent System and International Trade Agreements (2016) (1)
Generation 3.0 (2017) (1)
The Inventor's Contribution (2005) (1)
Viral Licensing: Ensuring the Public Interest When Taxpayers Fund Pharmaceutical Research (2018) (1)
Artificial Intelligence: The Importance of Trust & Distrust (2018) (1)
Patent Law: Empirical Evidence of Drug Pricing Games— A Citizen’s Pathway Gone Astray (2017) (1)
The Price Tag of 'Pay-for-Delay' (2021) (1)
Coming to the Community (2012) (1)
Internationalization of Science in Modern Law (2009) (1)
Understanding 'Evergreening': Making Minor Modifications Of Existing Medications To Extend Protections. (2022) (1)
Naked Price and Trade Secret Overreach (2019) (1)
The Devil is in the Tiers (2019) (1)
Pharmaceutical 'Pay-for-Delay' Reexamined: A Dwindling Practice or a Persistent Problem? (2019) (1)
Atomistic Antitrust (2021) (1)
Empirical Evidence of a Citizen's Pathway Gone Astray (2017) (1)
Startups and Unmet Legal Needs (2015) (1)
Improving the Role of Science in Law (2009) (0)
The Intellectual Property Landscape for iPS Cells (2009) (0)
5 The Interaction of Patents with Contracts and Antitrust (2012) (0)
The Cancer Curse (2020) (0)
“Generation 3.0”: New Tactics for Active Obstruction of Generics (2017) (0)
The Repetitions of History (2009) (0)
Patent Law: Finding Space for State Authority to Regulate Patents (2017) (0)
The devil in the tiers1 (2021) (0)
Patent Law: The Sound and Fury of Patent Activity (2020) (0)
Differing Shades of Meaning (2007) (0)
Identifying Extensions of Protection in Prescription Drugs: Navigating the Data Landscape for Large-Scale Analysis (2018) (0)
Empirical Evidence of Drug Companies Using Citizen Petitions to Hold Off Competition (2018) (0)
Universities and Patent Demands (2015) (0)
Federalism, Patents, and the Constitutionality of State Pharmaceutical Regulation (2018) (0)
“Generation 1.0”: The Rise and Fall of Traditional Pay-for-Delay (2017) (0)
Book Review of Pharma: Greed, Lies, and the Poisoning of America (2021) (0)
4 Where Do Processes of Nature End and Processes of Human Inventions Begin (2012) (0)
Brief of Amici Curiae 56 Professors of Law and Economics in Support of Petition of Writ of Certiorari (2016) (0)
Rewarding Failure with Patents (2022) (0)
HOUSE WAYS AND MEANS HEALTH SUBCOMMITTEE Promoting Competition to Lower Medicare Drug Prices (2019) (0)
Conclusion: A Call for Systematic Reform (2017) (0)
2 How Modern Patents Operate (2012) (0)
3 Implications of the Bargain Aspect for Current Debates (2012) (0)
The Allure of Science (2009) (0)
What is Science (2009) (0)
The Nature of Law (2009) (0)
“Generation 2.0”: Complicating Pay-for-Delay (2017) (0)
1 The Bargain Aspect of Patents (2012) (0)
May Your Drug Price Be Ever Green (Orange Book Project Dataset & Methodology) (2018) (0)
Externalization in Modern Law (2009) (0)
Patent Law: How Big Pharma Delays Generic Entry (2017) (0)
Lochner Revenant: The Dormant Commerce Clause & Extraterritoriality (2022) (0)
Panel I: The Scholar’s Perspective: Theories of Patent Trolling (2015) (0)
The Price Tag of "Pay-for-Delay" (2022) (0)
Prologue: Big Scandals, Higher Prices (2017) (0)
The Burden on Society from Eleventh-Hour 'Citizen Petitions' Filed to Slow Generic Drugs (2019) (0)
Trade Secrets in Biologic Medicine (2023) (0)
Purple is the New Orange (2023) (0)
Incentivizing Failure (2021) (0)
The Sound & Fury of Patent Activity (2018) (0)
6 Beyond the State of the Art (2012) (0)
Captive Generics: The Wolf in Sheep's Clothing (2021) (0)
Trolling Why Bio & Pharmaceuticals Are at Risk (2016) (0)
Societal Cost of Improper Citizen Petitions (2019) (0)
Leading with the Trailing Edge: Facilitating Patient Choice for Insulin Products (2023) (0)
Pharmaceutical Pipeline Divestitures Study: Preliminary Results (2021) (0)
Misunderstanding the Limits of Science (2009) (0)
Pharmacies, Doctors, and Patient Groups (2019) (0)
The Judges' Book The Judges' Book Health Law: The Unstoppable Growth of Prescription Drug Prices Health Law: The Unstoppable Growth of Prescription Drug Prices (2020) (0)
Trade Secrets and Biologic Medicine: A Conflict of Laws (2022) (0)
Remarks in Honor of the Legal and Public Policy Legacies of John Henry Merryman: Cultural Property and Human Cells (2014) (0)
Designing Disruption in Pharmaceuticals (2021) (0)
Transparency (2021) (0)
Challenges with Defining Pharmaceutical Markets and Potential Remedies to Screen for Industry Consolidation. (2022) (0)
The Arc of History in Patent Subject Matter (2020) (0)
Introduction: The Winding Road to Generic Entry (2017) (0)
Advertising Medicine: Who’s Minding the Store? (2022) (0)

This paper list is powered by the following services:

Other Resources About Robin Feldman

en.wikipedia.org

What Schools Are Affiliated With Robin Feldman?

Robin Feldman is affiliated with the following schools:

Robin Feldman's Academic­Influence.com Rankings

Robin Feldman's Degrees

Why Is Robin Feldman Influential?

Robin Feldman's Published Works

Published Works

Other Resources About Robin Feldman

What Schools Are Affiliated With Robin Feldman?

Robin Feldman's AcademicInfluence.com Rankings